Cortical interneurons establish inhibitory microcircuits throughout the neocortex and their dysfunction has been implicated in epilepsy and neuropsychiatric diseases. Developmentally, interneurons migrate from a distal progenitor domain in order to populate the neocortex -a process that occurs at a slower rate in humans than in mice. In this study, we sought to identify factors that regulate the rate of interneuron maturation across the two species. Using embryonic mouse development as a model system, we found that the process of initiating interneuron migration is regulated by blood vessels of the medial ganglionic eminence (MGE), an interneuron progenitor domain. We identified two endothelial cell-derived paracrine factors, SPARC and SerpinE1, that enhance interneuron migration in mouse MGE explants and organotypic cultures.
Introduction:
Cortical interneurons are inhibitory, locally projecting cells that form a distributed network of repetitive microcircuits throughout the cortex (Kepecs and Fishell, 2014; . To establish this distributed network, interneurons migrate from the ventral subpallium to arealize throughout the cortex in order to form connections with layered pyramidal neurons and other interneurons. The timescale for interneuron migration varies widely across species; The process lasts days in mice (Lavdas et al., 1999; Marin and Rubenstein, 2001) and several months in humans (Arshad et al., 2016; Hansen et al., 2013; Ma et al., 2013) . Further, this species difference extends to stem cell derived interneurons where mouse ES-derived interneurons develop rapidly (Au et al., 2013; Maroof et al., 2010; , while hSC-interneuron development is protracted (Nicholas et al., 2013; Shao et al., 2019) . Indeed, this limitation has restricted the scope of analysis on hSC-interneurons, hampering detailed functional studies.
In this study, we sought to identify factors that regulate the timing of interneuron migration across species. Using embryonic mouse development as a model system, we found that interneuron migration coincides with vascularization of the medial ganglionic eminence (MGE). In fact, by genetically manipulating the degree of MGE vascularization in vivo, we can alter the degree of interneuron migration into the cortex. Using an in vitro approach, we identified paracrine factors, SPARC and SerpinE1 produced by endothelial cells that enhance interneuron migration in mouse MGE explants and organotypic cultures. Given the slow developmental rate of hSC-interneurons, we tested whether SPARC and SerpinE1 treatment similarly induced migration in human cells. We found that treated hSC-interneurons xenografted into neonatal mouse cortex exhibited enhanced migration. Further, transplanted hSC-interneurons also showed greater morphological complexity, and more mature electrophysiological characteristics compared to controls. These data suggest that interneurons in mice and humans share a common vascular-based mechanism that regulates their developmental timing. Notably, by characterizing this process in mice, we were able to reverse-engineer our findings to accelerate functional maturation in human interneurons.
Results:
Cortical interneurons are generated from a distal source (primarily the medial gangionic eminence, MGE) and undergo long distance migration to their final destination in the neocortex.
In the embryonic mouse, this developmental process is rapid: interneurons are generated starting approximately e11 and robustly migrate into the cortex by e15 ( Figure 1A ) (Lavdas et al., 1999; Marin and Rubenstein, 2001) . As a result, it is tempting to assume that newly born interneurons automatically transition to a migratory state. As a counter example, however, in human fetal development interneuron migration into the cortex is highly protracted. Previous studies have found that postmitotic interneurons slowly transition to a migratory state to populate the neocortex over the course of many weeks (Arshad et al., 2016; Hansen et al., 2013; Ma et al., 2013) . To confirm this, we examined interneurons in fetal cortical sections by immunohistochemistry for Dlx2 (an interneuron marker). Consistent with prior reports, we observed an increase in the density of Dlx2 + interneurons in the cortex over time (15 post conception weeks (pcw) to 22 pcw) ( Figure 1B, Figure S1A ,B). We hypothesized that the discrepancy between human and mouse interneuron development may be due to an external cue delivered to the MGE to promote interneuron migration. We therefore examined the developing mouse MGE (from e10.5 to e15.5) by histology and observed a striking increase in vascularization of the MGE and the underlying mantle region during the time period when mouse interneuron migration initiates ( Figure 1C , D) (Daneman et al., 2009; Paredes et al., 2018) .
Similarly, we found that vascularization of human fetal MGE slowly increased with developmental age, with robust vascularization not occurring until after 20 pcw ( Figure 1E , Figure S1C ,D).
To determine whether there is a causal relationship between MGE vascularization and interneuron migration, we examined Apcdd1 mutant mice (Mazzoni et al., 2017) . Apcdd1 a negative regulator of Wnt/b-catenin signaling, that is critical for CNS vascular development and blood-brain barrier maturation (Shimomura et al., 2010) . We examined MGE vessel density and average vessel size in Apcdd1 GOF and LOF mutants at e14.5 and found that, similar to the retina and cerebellum (Mazzoni et al., 2017) , vascularization in the MGE is decreased in Apcdd1 GOF and increased in Apcdd1 LOF mice versus wildtype controls ( Figure 1F -H). Importantly, fewer interneurons migrated into the cortex in Apcdd1 GOF mutants, in which vascularization was less extensive compared to wild type controls. Conversely, a trend towards more Calbindin+ migrating interneurons were present in Apcdd1 LOF mutants (p=0.236, paired t-test) in which vessel size and density was greater ( Figure 1I ). These results suggest that the density of endothelial cells within neural tissue is a critical regulator interneuron migration.
In order to identify a mechanism by which this occurs, we used an MGE explant culture approach from mouse embryos to examine the number of migrating neurons at various developmental stages (Figure 2A , Figure S2A ). Given that the MGE is progressively vascularized from e10 to e15, we reasoned that MGE explants may exhibit a developmental age-dependent capacity to migrate from the explant. We further reasoned that in early MGE explants that were not extensively vascularized that mouse interneurons would be similarly immobile like human interneurons. To normalize for differences in MGE size at different ages, whole MGE tissue was dissected and sectioned at 250 microns. Then, the number of DAPI+ migratory cells was normalized to the surface area of the MGE explant. Using this approach, we found a strong linear correlation between the number of migratory cells and MGE explant surface area (r 2 =0.6829) ( Figure S2B ). Further, we found that nearly all migratory DAPI+ cells were interneurons using the Dlx6a Cre driver line crossed to Ai9 in order to fate map the migratory lineage (Monory et al., 2006) ( Figure S2C ,D). Classic studies have shown that MGE explants at e14.5 and e15.5 exhibit robust interneuron migration within hours of initial plating (Bellion et al., 2005; Polleux et al., 2002; Wichterle et al., 1999) . Consistently, we found that interneurons later time point MGE explants exhibited robust migration, whereas explants from earlier time points (e10.5 to e12.5) had a limited capacity to migrate ( Figure 2B , Figure S2C ). One possibility is that interneurons possess an intrinsic timer such that, given sufficient time in culture, early timepoint explants would migrate to the same extent as older MGE explants. However, even when cultured for up to a week, early explants did not significantly migrate more after the first 48 hours (data not shown).
Given the diffuse distribution of blood vessels in the MGE, the most likely mechanism is that endothelial cells produce a paracrine signal to induce interneuron migration. To test this directly, we prepared conditioned medium from primary cultures of embryonic brain ECs (p-EndoCM) and added it to e11.5 MGE explants. Consistent with our hypothesis, addition of p-EndoCM resulted in a robust increase in interneuron migration ( Figure 2C ). We found, however, that primary embryonic brain EC cultures introduced unwanted variability, and for subsequent experiments, we obtained Endo-CM from an immortalized human EC line, HBEC5i (Wassmer et al., 2006) . To further reduce inter-experimental variability, interneuron migration counts were normalized to within-experiment negative (untreated) controls. Hence, subsequent data is presented as fold-change in interneuron migration over controls. Similar to p-Endo CM, conditioned medium from HBEC-5i (Endo CM) also robustly increased e11.5 MGE explant migration ( Figure 2C ). Interestingly, e14.5 MGE migration was also significantly increased by EndoCM ( Figure 2C ). We next tested the effect of EndoCM on interneuron migration in an organotypic slice culture. Here, we used Dlx6a Cre ; Ai9+ e11.5 embryos in order to visualize interneurons as they migrate within a coronal slice of telencephalon from the MGE into the cortex (Figure 2A ,E). As with MGE explants, EndoCM also significantly increased the rate and overall number of interneurons that migrated into the cortex ( Figure 2F ). As a negative control, we tested the biological activity of conditioned medium from HEK 293 cells (HEK CM). HEK CM did not increase MGE explant migration at either age ( Figure 2D ). Moreover, we found that preboiling EndoCM eliminated its biological activity, suggesting a protein source as a regulator of interneuron migration ( Figure 2D ). Finally, we size-fractionated EndoCM and found that biological activity was strongly reduced between 30 kDa and 100 kDa ( Figure 2G ).
In order to identify candidate proteins, we performed bulk RNA sequence analysis on HBEC5i and HEK cells. We screened the dataset for genes with the greatest differential expression, enriched in HBEC5i that produced proteins between 30 and 100 kDa, which were also secreted (GO term: extracellular space) ( Figure S3 ). After further curation to eliminate membrane-tethered molecules, we obtained a short list of 24 candidates ( Table 1) . We functionally tested a number of candidates, including VEGF-A (Barber et al., 2018) and Follistatin; however, two proteins, SPARC and Serpin E1 exhibited the most robust biological activity in their ability to increase e11 MGE migration ( Figure 3 ).
We examined the expression of SPARC and Serpin E1 in e14.5 MGE through publiclyavailable expression databases (Allen Brain Atlas and Gene Paint), and found that both were specifically expressed in the embryonic CNS vasculature ( Figure 3A,B ). We also confirmed by western blotting that SPARC and SerpinE1 were present in EndoCM at significantly higher levels compared to HEK293 CM ( Figure 3C ,D). We then added recombinant SPARC or SerpinE1 to MGE explants and found that cell migration was increased, in particular with SerpinE1 ( Figure 3E ). We then tested EndoCM in which SPARC and Serpin E1 activity were depleted. We used a functionblocking antibody for SPARC , whereas Serpin E1 activity was blocked with a small molecule inhibitor (SK216 ). These reagents separately significantly reduced the capacity of Endo CM to increase e11.5 MGE migration ( Figure 3F ).
However, inhibition of both SPARC and SerpinE1 did not reduce interneuron migration further, suggest that the two molecules may act on intersecting pathways. Finally, we tested whether SPARC and Serpin E1 could increase interneuron migration in an organotypic slice over time. We found that both proteins significantly increased the rate and overall number of interneurons that migrated into the cortex over time ( Figure 3G ). SPARC and SerpinE1 have been shown to inhibit both endothelial cell migration and proliferation (Boyineni et al., 2016; Hasselaar and Sage, 1992; Lane et al., 1994; Menashi et al., 1993) .
Previous studies have demonstrated that hSC-interneurons migrate and mature at a slow rate, reminiscent of the protracted time frame of interneuron development in the human fetus (Arshad et al., 2016; Hansen et al., 2013; Ma et al., 2013) . Given that SPARC and Serpin E1 elicit interneuron migration in e11.5 MGE explants and organotypic slice cultures, we tested whether these factors might similarly accelerate the developmental timeframe for hSC-interneurons.
Using a pan-tdTomato expressing human iPSC line (CAG-tdTomato knocked into AAVS1 locus), we achieved efficient differentiation to ventral telencephalic identity using established protocols ) ( Figure S4 ). hSC-interneuron differentiation was confirmed using AAV Dlx5/6-GFP (Dimidschstein et al., 2016) (Figure S4B ). At day 35 of differentiation (DIFF 35), ventral telencephalic organoids were treated with either SPARC, Serpin E1 or both for 14 days in order to observe a biological effect in vitro (data not shown). At DIFF 49, we tested for hSC-interneuron migration by dissociating either untreated and SPARC and SerpinE1-treated organoids. Here, we further divided the groups: one group continued to be exposed to SPARC and SerpinE1 and the other was left untreated ( Figure S5A ). We observed a significant increase in migratory distance in the treated group. Importantly, we observed an even greater biological effect when SPARC and Serpin were added to dissociated cells after pre-treatment ( Figure S7c ). Thus, in subsequent xenograft experiments, SPARC and SerpinE1 was added as a pre-treatment for 14 days and also added to the cells at the time of transplantation.
Previous studies have xenografted hSC-interneurons into a more functionally relevant setting: neonatal mouse cortex. They found that functional maturation rate is prolonged, requiring approximately 7 months (Nicholas et al., 2013; Shao et al., 2019) . We then tested the capacity of control and SPARC/SerpinE1-treated ventral organoids to integrate following xenotransplant into immune-compromised (NSG) mouse cortex. We first analyzed transplants 28 days post engraftment. We confirmed that tdTomato+ hSC-interneurons were almost all Dlx2+ ( Figure 4A ), and also found that Combo-treated hSC-interneurons migrated significantly further than controls ( Figure 4B ,C). At 56 days post-transplantation, we traced and analyzed the morphologies of hSC-interneurons in 3D and found that they possessed longer processes and branched more extensively ( Figure 4D , Figure S6 ).
Given the improvements in migration and morphology exhibited by treated hSCinterneurons, we tested their functional maturity by employing whole cell recordings from Tdtomato labelled transplanted cells in acute slices of frontal cortex 56 days post-transplant.
Consistent with more mature neuronal function, recordings from treatment group neurons showed significantly reduced membrane input resistance, faster membrane time constants, more hyperpolarized action potential thresholds, and increased ratios of voltage gated sodium currents versus voltage gated potassium currents ( Figure 4E-O) . Additionally, other measures of neuronal maturity we tested appeared to collectively trend towards more mature functional phenotypes in the treatment group of neurons, albeit these were not statistically significant ( Figure S7 ). Specifically, treated cells appear to have larger membrane capacitances (p=0.067), more hyperpolarized resting potentials (p=0.12), larger voltage gated sodium currents (p=0.20), faster AP rise rates (p=0.21), narrower APs (p=0.22), and generated a greater number of APs (p=0.24) ( Figure S9 ). Taken together, these electrophysiological profiles suggest that treated neurons may have an accelerated trajectory towards functional maturity.
Discussion:
CNS vascularization is a tightly regulated process that operates in tandem with neuronal and glial cell development (Paredes et al., 2018) . Here, we demonstrate that not only does vascularization of mouse MGE coincide with interneuron migration, but it also plays a regulatory role since genetic manipulation of vascular pruning affects the number of interneurons migrating into the cortex. Further, two EC-derived paracrine factors SPARC and Serpin E1 induce increased interneuron migration as assessed by in vitro assays. Having demonstrated a critical crosstalk between the neural and vascular compartments in mouse, we leveraged our findings to test if SPARC and SerpinE1 can accelerate hSC-interneuron maturation. We found that hSCinterneurons treated with SPARC and Serpin E1 also show a more robust migration both in vitro and upon xenotransplantation into host mouse cortex. Finally, xenografted hSC-interneurons also exhibit significantly more complex morphologies and some mature electrophysiological properties.
Our findings support previous studies that have linked angiogenesis to pathfinding during interneuron tangential migration (Barber et al., 2018; Li et al., 2018) and MGE mitosis (Tan et al., 2016) . Further, radial glia in the MGE undergo a transition during embryonic development where their pial endfeet detach and connect to MGE vasculature (Tan et al., 2016) . In light of our data, it is tempting to speculate that this rearrangement allows for a more direct communication between ECs and interneurons, thereby facilitating their tangential migration into the cortex. In humans, interneuron migration during fetal development is a protracted process (Arshad et al., 2016; Hansen et al., 2013; Ma et al., 2013) . We found that hSC-interneurons exhibit greater migration and faster functional maturation when treated with vascular factors, SPARC and SerpinE1, suggesting that the maturation of CNS vasculature may similarly regulate the timing of human fetal interneurons migration. In support of this, the MGE (also known as the germinal matrix) is the primary site periventricular hemorrhages (PVH) in prematurely-born babies (Luo et al., 2019) . It has been hypothesized that this is due to newly formed (and thus weaker) vasculature in the MGE during the third trimester (Ballabh et al., 2004; Ballabh et al., 2007) . As such, it is an appealing possibility that the timing of vascularization helps to coordinate speciesspecific aspects of neuronal maturation. Here, delayed vascularization in humans may serve a regulatory role in delaying interneuron migration until pyramidal neurons have achieved sufficient maturity to allow for interneuron circuit integration.
We identified SPARC and SerpinE1 as important proteins that account for most of the EndoCM activity. Both factors are known to be secreted by ECs, and SPARC has been implicated in cell differentiation (Hrabchak et al., 2008; Stary et al., 2005) and migration such as regulation of the epithelial-to-mesenchymal transition and cancer metastasis (Arnold and Brekken, 2009 ). SerpinE1 (also known as plasminogen activator inhibitor-1, PAI-1) is also implicated in cell migration through the uPA/Urokinase pathway (Mahmood et al., 2018) , which has been shown to control interneuron tangential migration by acting through the c-Met receptor and hepatocyte growth factor(HGF) (Powell et al., 2001) . This raises the possibility that SerpinE1 effects may intersect with the HGF/c-Met pathway. Future studies will elucidate the pathways activated by SPARC and SerpinE1 to promote interneuron migration and functional maturation.
Of note, we empirically determined that human ventral telencephalic organoids require approximately 14 days pre-treatment with SPARC and SerpinE1 before we could detect enhanced migration in vitro. This may reflect a human-specific difference in responding to endothelial cues compared with mouse interneurons that operate under a more compressed timescale. In fact, this may account for previous observations by Nicholas and colleagues that migration of hSCinterneurons into host mouse cortex occurs at a slow rate over 7 months (Nicholas et al., 2013) . This may be explained by host vascularization of the xenograft, which has been shown to occur over a period of months (Mansour et al., 2018) . We hypothesize that pretreatment with SPARC and SerpinE1 allows our xenograft to bypass host vascularization as a means to trigger migration. Therefore, pretreatment may prime hSC-interneurons to more rapidly integrate and mature into the host cortex.
Our findings demonstrate the utility of priming hSC-interneurons for transplantation by pre-inducing them to adopt a migratory state. Although, there are likely other impediments to overcome before hSC-interneurons are fully synchronized with the developmental timescale of host mouse cortex, our findings represent an important step towards harnessing the full potential of hSC-interneurons. Cortical interneurons are critical modulators of brain function (Kepecs and Fishell, 2014; Tremblay et al., 2016) and it is important to develop human interneuron models of disease (Catterall, 2018; Inan et al., 2013; Marin, 2012; Rapanelli et al., 2017) . Moreover, our pre-treated hSC-interneurons also exhibit more maturity in vitro, suggesting SPARC/SerpinE1 treatment may also be effective when applied to organoid and monolayer approaches. Finally, consistent with previous work (Karakatsani et al., 2019) , Paired t-test, * p < 0.05; **p < 0.01; *** p < 0.001. * from Allen Brain Atlas (http://developingmouse.brain-map.org/); # from Gene Paint (http://gp3.mpg.de). 100 uM For untreated controls, the appropriate vehicle at the same volume was added to x medium.
Vehicle for p-EndoCM and EndoCM: Neurobasal Vehicle for SPARC: water Vehicle for SerpinE1: PBS Vehicle for Sparc function-blocking antibody: PBS; Vehicle for SK216: water.
Organotypic Slice Culture Migration Assay
We employed a modified protocol previously described (Baffet et al., 2016) . Briefly, Dlx6a Cre ;
Ai9 e11.5 embryos were sac'd and whole brain was isolated by microdissection in aCSF medium bubbled with O2. Brains were embedded in low melt agarose (4 %) in aCSF medium and sectioned by vibratome at a thickness of 250 microns. Sections were imaged live daily by confocal microscopy. Images were analyzed using Image J plugin trackMate in order to automatically segment and quantify migrating interneurons in cortex.
Derivation of Conditioned Medium
Primary culture endothelial cells were derived as previously described (Baffet et al., 2016) and maintained in complete mouse endothelial cell medium from Cell Biologics. To collect p-EndoCM, cells were rinsed with PBS and then medium was switched to Neurobasal and 1%
Glutamax for 3 days. Supernatant was collected, centrifuged at 4,000 x g for 15 minutes and filtered to remove cells. Then medium was concentrated using a 3000 kDa MWCO Centricon column (Millipore) . Concentrated medium was stored at -80 o C until use. Similarly, HBEC-5i cells were maintained in (DMEM/F12, 10%FBS, 40 ug/mL Endothelial Cell Growth Supplement) medium, rinsed with PBS and then switched to Neurobasal, 1% Glutamax medium for 3 days.
EndoCM was similarly spun down, filtrated and concentrated using 3000 kDa MWCO Centricon column (Millipore) . Concentrated EndoCM was also stored at -80 o C until use. For size fractionation experiments, 10, 50 and 100 kDa MWCO Centricon columns (Millipore) were used for media concentration. HEK 293 cells were maintained in DMEM, 10%FBS, 1% Glutamax medium and switched to Neurobasal, 1% Glutamax medium following PBS rinses to collect HEK CM. It was also concentrated using 3000 kDa MWCO Centricon columns.
RNA Sequence Analysis
HBEC-5i and HEK 293 cells were switched over to Neurobasal, 1% Glutamax medium in the same manner as if EndoCM and HEK CM were to be collected. 3 days later, cells were harvested in Trizol and RNA was purified using directZol miniPrep kit (Zymo). Samples were quality controlled and sequenced at Novogene using Illumina HigSeq/MiSeq with a sequencing depth of 20 million reads. Sequence data was then analyzed using DAVID to identify high confidence differentially-expressed hits of the appropriate molecular weight. These data were further screened by Gene Ontology search term "Extracellular Space" to identify secreted factors.
Additional curation was performed to remove membrane-tethered proteins and pseudogenes in order to arrive at a short list of candidates (Table 1) .
Immunohistochemistry and Western Blots
Immunohistochemistry on Apcdd1 mutants were as described previously . E14.5 Apcdd1 mutant and wildtype control brains were cryosectioned at 16 microns and immunolabeled with Alexa488-tagged Isolectin (1:100; Thermo Fisher Scientific); Calbindin (1:1,1000; ImmunoStar). Sections were acquired as tiled maximum projection images for
